Variants of Genes Implicated in Type 1 Interferon Pathway and B-Cell Activation Modulate the EULAR Response to Rituximab at 24 Weeks in Rheumatoid Arthritis

RMD Open - United Kingdom
doi 10.1136/rmdopen-2017-000448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Interferon Type I Signature Towards Prediction of Non-Response to Rituximab in Rheumatoid Arthritis Patients

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2012English

Non-Response to Rituximab Therapy in Rheumatoid Arthritis Is Associated With Incomplete Disruption of the B Cell Receptor Repertoire

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Activation of the Type I Interferon Pathway Is Enhanced in Response to Human Neuronal Differentiation

PLoS ONE
Multidisciplinary
2013English

Safety of Rituximab in Rheumatoid Arthritis

Reumatismo
Rheumatology
2011English

Genetic Polymorphisms in Key Methotrexate Pathway Genes Are Associated With Response to Treatment in Rheumatoid Arthritis Patients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2012English

NK Cell Count as Predictor of Clinical Response in Patients With Rheumatoid Arthritis Treated With Rituximab

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Improvements in Clinical Response Between 12 and 24 Weeks in Patients With Rheumatoid Arthritis on Etanercept Therapy With or Without Methotrexate

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

A Combination of Cellular Biomarkers Predicts Failure to Respond to Rituximab in Rheumatoid Arthritis: A 24-Week Observational Study

Arthritis Research & Therapy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy